These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36052831)

  • 1. Comment on 'Morphoea following COVID-19 vaccination'.
    Martora F; Battista T; Ruggiero A; Fabbrocini G; Potestio L
    Clin Exp Dermatol; 2022 Dec; 47(12):2312-2313. PubMed ID: 36052831
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphoea following COVID-19 vaccination.
    Oh DAQ; Tee SI; Heng YK
    Clin Exp Dermatol; 2022 Dec; 47(12):2293-2295. PubMed ID: 35906013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphoea and COVID-19 vaccination.
    Sookaromdee P; Wiwanitkit V
    Clin Exp Dermatol; 2022 Nov; 47(11):2045. PubMed ID: 35934951
    [No Abstract]   [Full Text] [Related]  

  • 4. Correspondence on 'Herpes Zoster and Simplex reactivation following COVID-19 vaccination'.
    Mungmunpuntipantip R; Wiwanitkit V
    Expert Rev Vaccines; 2022 Aug; 21(8):1159. PubMed ID: 35471143
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on 'Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination'.
    Martora F; Battista T; Fabbrocini G; Potestio L
    Clin Exp Dermatol; 2023 Jan; 48(1):35-36. PubMed ID: 36669175
    [No Abstract]   [Full Text] [Related]  

  • 6. A Case of Morphea After COVID-19 Vaccination.
    Sharma A; Sandhu A
    Dermatitis; 2024; 35(2):187-188. PubMed ID: 37610869
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 vaccination in a cancerous patient: A comment.
    Mungmungpuntipantip R; Wiwanitkit V
    J Cancer Res Ther; 2021; 17(6):1587. PubMed ID: 34916404
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on: 'Acute macular neuroretinopathy following COVID-19 vaccination'.
    Chen S; Hodge C
    Eye (Lond); 2022 Jul; 36(7):1513-1514. PubMed ID: 34584235
    [No Abstract]   [Full Text] [Related]  

  • 9. Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.
    Antoñanzas J; Rodríguez-Garijo N; Estenaga Á; Morelló-Vicente A; España A; Aguado L
    Dermatol Ther; 2022 Sep; 35(9):e15709. PubMed ID: 35811413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to 'Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination'.
    Lee E; Chew NWS; Ng P; Yeo TJ
    QJM; 2022 Jul; 115(7):500-501. PubMed ID: 34463770
    [No Abstract]   [Full Text] [Related]  

  • 11. General determination of causation between Covid-19 vaccines and possible adverse events.
    Hampton LM; Aggarwal R; Evans SJW; Law B
    Vaccine; 2021 Mar; 39(10):1478-1480. PubMed ID: 33558107
    [No Abstract]   [Full Text] [Related]  

  • 12. Morphea and COVID-19 mRNA vaccine.
    Sookaromdee P; Wiwanitkit V
    Int J Dermatol; 2022 May; 61(5):e162. PubMed ID: 35230704
    [No Abstract]   [Full Text] [Related]  

  • 13. [Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management].
    Worm M; Ring J; Klimek L; Jakob T; Lange L; Treudler R; Beyer K; Werfel T; Biedermann T; Bircher A; Fischer M; Fuchs T; Heller AR; Hoffmann F; Huttegger I; Kopp MV; Kugler C; Lommatzsch M; Pfaar O; Rietschel E; Rueff F; Schnadt S; Seifert R; Stöcker B; Vogelberg C; Sitter H; Gieler U; Brockow K
    MMW Fortschr Med; 2021 Jan; 163(1):48-51. PubMed ID: 33464512
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocarditis Temporally Associated With COVID-19 Vaccination.
    Rosner CM; Genovese L; Tehrani BN; Atkins M; Bakhshi H; Chaudhri S; Damluji AA; de Lemos JA; Desai SS; Emaminia A; Flanagan MC; Khera A; Maghsoudi A; Mekonnen G; Muthukumar A; Saeed IM; Sherwood MW; Sinha SS; O'Connor CM; deFilippi CR
    Circulation; 2021 Aug; 144(6):502-505. PubMed ID: 34133885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute disseminated encephalomyelitis and COVID-19 vaccination: Comment.
    Kleebayoon A; Wiwanitkit V
    J Clin Neurosci; 2023 Sep; 115():164. PubMed ID: 37088619
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'.
    Martora F; Marasca C; Battista T; Fabbrocini G; Ruggiero A
    Clin Exp Dermatol; 2022 Nov; 47(11):2026-2028. PubMed ID: 35727206
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to 'New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination'.
    Magnaterra E; Mariotti EB; Corrà A; Aimo C; Quintarelli L; Ruffo di Calabria V; Verdelli A; Caproni M
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):e366-e367. PubMed ID: 38069559
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on self-reported symptoms after COVID-19 vaccination.
    Kleebayoon A; Wiwanitkit V
    Intern Emerg Med; 2023 Nov; 18(8):2457-2458. PubMed ID: 37715065
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effects on female fertility from vaccination against COVID-19 unlikely.
    Markert UR; Szekeres-Bartho J; Schleußner E
    J Reprod Immunol; 2021 Nov; 148():103428. PubMed ID: 34601377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to Response to "'A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination'" by Mungmunpuntipantip and Wiwanitkiton.
    Masuta Y; Watanabe T; Minaga K; Kudo M
    Inflamm Bowel Dis; 2022 Aug; 28(8):e113. PubMed ID: 35394530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.